<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   1720
  </number>
  <updateDate>
   2023-03-08T19:58:39Z
  </updateDate>
  <updateDateIncludingText>
   2023-03-08T19:58:39Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-03-09
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 44 (Tuesday, March 9, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. VARGAS:H.R. 1720.Congress has the power to enact this legislation pursuantto the following:(1) To regulate commerce with foreign nations, and amongthe several states, and with the Indian tribes, as enumeratedin Article 1, Section 8, Clause 3 of the U.S. Constitution;(2) To make all laws necessary and proper for executingpowers vested by the Constitution in the Government of theUnited States, as enumerated in Article I, Section 8, Clause18 of the United States Constitution.[Page H1191]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsba00
    </systemCode>
    <name>
     Financial Services Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-03-09T15:06:05Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     American Rescue Plan Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     1319
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2021-03-11
     </actionDate>
     <text>
      Became Public Law No: 117-2.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-03-09
    </actionDate>
    <text>
     Referred to the House Committee on Financial Services.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsba00
      </systemCode>
      <name>
       Financial Services Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-03-09
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-03-09
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     V000130
    </bioguideId>
    <fullName>
     Rep. Vargas, Juan [D-CA-51]
    </fullName>
    <firstName>
     Juan
    </firstName>
    <lastName>
     Vargas
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     51
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     W000187
    </bioguideId>
    <fullName>
     Rep. Waters, Maxine [D-CA-43]
    </fullName>
    <firstName>
     MAXINE
    </firstName>
    <lastName>
     WATERS
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     43
    </district>
    <sponsorshipDate>
     2021-03-09
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Appropriations
     </name>
    </item>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Government Operations and Politics
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Military procurement, research, weapons development
     </name>
    </item>
    <item>
     <name>
      Public contracts and procurement
     </name>
    </item>
    <item>
     <name>
      Worker safety and health
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-03-09
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-07-15T19:45:01Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;COVID-19 Medical Production Act&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.&lt;/p&gt; &lt;p&gt;This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   COVID–19 Medical Production Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     COVID–19 Medical Production Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To provide additional funding under the Defense Production Act of 1950 related to medical supplies and equipment directly related to combating the COVID-19 pandemic, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     COVID–19 Medical Production Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-03-09T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr1720ih/xml/BILLS-117hr1720ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-03-09
   </actionDate>
   <text>
    Referred to the House Committee on Financial Services.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

H11100
2021-03-09
Financial Services Committee
hsba00
2
House floor actions
Referred to the House Committee on Financial Services.
IntroReferral
Intro-H
2021-03-09
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-09
9
Library of Congress
Introduced in House
IntroReferral
2021-03-09T15:06:05Z
Referred to
House
Financial Services Committee
hsba00
Standing
W000187
43
MAXINE
Rep. Waters, Maxine [D-CA-43]
WATERS
D
2021-03-09
CA
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-03-09
2021-03-09
Referred to the House Committee on Financial Services.
House
Health
2021-03-11
Became Public Law No: 117-2.
CRS
Related bill
American Rescue Plan Act of 2021
HR
V000130
51
Juan
Rep. Vargas, Juan [D-CA-51]
N
Vargas
D
CA
Appropriations Cardiovascular and respiratory health Emergency medical services and trauma care Government Operations and Politics Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Manufacturing Medical tests and diagnostic methods Military procurement, research, weapons development Public contracts and procurement Worker safety and health
2021-03-09
Introduced in House
 <p><strong>COVID-19 Medical Production Act</strong></p> <p>This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.</p> <p>This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.</p>
2021-07-15T19:45:01Z
00
2021-03-09T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr1720ih/xml/BILLS-117hr1720ih.xml
COVID–19 Medical Production Act
COVID–19 Medical Production Act
Display Title
IH
Introduced in House
To provide additional funding under the Defense Production Act of 1950 related to medical supplies and equipment directly related to combating the COVID-19 pandemic, and for other purposes.
Official Title as Introduced
IH
Introduced in House
COVID–19 Medical Production Act
Short Title(s) as Introduced
HR
2023-03-08T19:58:39Z
2023-03-08T19:58:39Z
3.0.0
2021-03-11
Became Public Law No: 117-2.
CRS
Related bill
American Rescue Plan Act of 2021
HR
H11100
2021-03-09
Financial Services Committee
hsba00
2
House floor actions
Referred to the House Committee on Financial Services.
IntroReferral
Intro-H
2021-03-09
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-09
9
Library of Congress
Introduced in House
IntroReferral
V000130
51
Juan
Rep. Vargas, Juan [D-CA-51]
N
Vargas
D
CA
W000187
43
MAXINE
Rep. Waters, Maxine [D-CA-43]
WATERS
D
2021-03-09
CA
Appropriations Cardiovascular and respiratory health Emergency medical services and trauma care Government Operations and Politics Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Manufacturing Medical tests and diagnostic methods Military procurement, research, weapons development Public contracts and procurement Worker safety and health
2021-03-09
Introduced in House
 <p><strong>COVID-19 Medical Production Act</strong></p> <p>This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.</p> <p>This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.</p>
2021-07-15T19:45:01Z
00
COVID–19 Medical Production Act
COVID–19 Medical Production Act
Display Title
IH
Introduced in House
To provide additional funding under the Defense Production Act of 1950 related to medical supplies and equipment directly related to combating the COVID-19 pandemic, and for other purposes.
Official Title as Introduced
IH
Introduced in House
COVID–19 Medical Production Act
Short Title(s) as Introduced
2021-03-09
Referred to the House Committee on Financial Services.